Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people.

Sung KC, Wild SH, Kwag HJ, Byrne CD.

Diabetes Care. 2012 Nov;35(11):2359-64. doi: 10.2337/dc12-0515. Epub 2012 Jul 24.

2.

Lipoprotein (a), metabolic syndrome and coronary calcium score in a large occupational cohort.

Sung KC, Wild SH, Byrne CD.

Nutr Metab Cardiovasc Dis. 2013 Dec;23(12):1239-46. doi: 10.1016/j.numecd.2013.02.009. Epub 2013 Jun 17.

PMID:
23786824
3.

Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).

Bertoni AG, Wong ND, Shea S, Ma S, Liu K, Preethi S, Jacobs DR Jr, Wu C, Saad MF, Szklo M.

Diabetes Care. 2007 Nov;30(11):2951-6. Epub 2007 Aug 17.

PMID:
17704348
4.

Fatty Liver, Insulin Resistance, and Obesity: Relationships With Increase in Coronary Artery Calcium Over Time.

Sung KC, Ryu S, Lee JY, Lee SH, Cheong ES, Wild SH, Byrne CD.

Clin Cardiol. 2016 Jun;39(6):321-8. doi: 10.1002/clc.22529. Epub 2016 Mar 21.

5.

Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis.

Sung KC, Cha SC, Sung JW, So MS, Byrne CD.

Nutr Metab Cardiovasc Dis. 2014 Mar;24(3):256-62. doi: 10.1016/j.numecd.2013.07.005. Epub 2013 Oct 9.

PMID:
24361070
6.

[Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation].

Andreozzi P, Viscogliosi G, Colella F, Subic M, Cipriani E, Marigliano B, Verrusio W, Servello A, Ettorre E, Marigliano V.

Recenti Prog Med. 2012 Dec;103(12):570-4. doi: 10.1701/1206.13358. Italian.

PMID:
23258240
7.

Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosis.

Sung KC, Wild SH, Byrne CD.

Atherosclerosis. 2013 Dec;231(2):181-6. doi: 10.1016/j.atherosclerosis.2013.09.009. Epub 2013 Sep 25.

PMID:
24267222
8.

The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults.

Ju DY, Choe YG, Cho YK, Shin DS, Yoo SH, Yim SH, Lee JY, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI.

Clin Mol Hepatol. 2013 Jun;19(2):140-7. doi: 10.3350/cmh.2013.19.2.140. Epub 2013 Jun 27.

9.

Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients.

Koh JH, Shin YG, Nam SM, Lee MY, Chung CH, Shin JY.

Diabetes Care. 2009 Jan;32(1):147-52. doi: 10.2337/dc08-1379. Epub 2008 Oct 3.

10.

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.

Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S.

Hepatology. 2008 Sep;48(3):792-8. doi: 10.1002/hep.22429.

PMID:
18752331
11.

Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis.

Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V.

Int J Obes (Lond). 2008 Feb;32(2):381-7. Epub 2007 Dec 18.

PMID:
18087267
12.

Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.

Targher G, Bertolini L, Rodella S, Zoppini G, Zenari L, Falezza G.

Clin Endocrinol (Oxf). 2006 Mar;64(3):337-41.

PMID:
16487446
13.

Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients.

Targher G, Bertolini L, Padovani R, Poli F, Scala L, Zenari L, Zoppini G, Falezza G.

J Endocrinol Invest. 2006 Jan;29(1):55-60.

PMID:
16553034
14.

Plasma adiponectin is a more specific marker of fatty liver than a marker of metabolic syndrome in Japanese men.

Yatsuzuka S, Shimomura Y, Akuzawa M, Ando Y, Kobayashi I, Nakano T, Tokita Y, Nagamine T, Ono H, Tanaka A, Schaefer E, Nakajima K.

Ann Clin Biochem. 2014 Jan;51(Pt 1):68-79. doi: 10.1177/0004563213487892. Epub 2013 Jul 29.

PMID:
23897104
15.

Association between Insulin Resistance, Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Chinese Adults.

Ying X, Jiang Y, Qian Y, Jiang Z, Song Z, Zhao C.

Iran J Public Health. 2012;41(1):45-9. Epub 2012 Jan 31.

16.

Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects.

Kim YC, Cho YK, Lee WY, Kim HJ, Park JH, Park DI, Sohn CI, Jeon WK, Kim BI, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Kim SW, Ryu SH.

J Nutr Biochem. 2011 Mar;22(3):289-92. doi: 10.1016/j.jnutbio.2010.02.007. Epub 2010 Jun 25.

PMID:
20579864
17.

Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.

Yoo J, Lee S, Kim K, Yoo S, Sung E, Yim J.

Diabetes Res Clin Pract. 2008 Sep;81(3):321-6. doi: 10.1016/j.diabres.2008.05.006. Epub 2008 Jun 20.

PMID:
18571268
18.

Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.

Onat A, Hergenç G, Türkmen S, Yazici M, Sari I, Can G.

Metabolism. 2006 Apr;55(4):445-52.

PMID:
16546474
19.

Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology.

Della Corte C, Fintini D, Giordano U, Cappa M, Brufani C, Majo F, Mennini C, Nobili V.

Clin Endocrinol (Oxf). 2013 Jul;79(1):49-54. doi: 10.1111/j.1365-2265.2012.04498.x. Epub 2013 Mar 25.

PMID:
22789032
20.

Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.

Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW.

Diabetes. 2005 Nov;54(11):3252-7.

Supplemental Content

Support Center